Lauriano, Grace D.

HRN: 27-25-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2026
CO-AMOXICLAV 625MG (TAB)
02/19/2026
02/26/2026
PO
625mg
BID X 7 Days
UTI; Thinly MSAF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: